WebFX reports OpenAI's launch of ChatGPT Apps and SDK enables seamless user interactions and providing developers tools to reach 800M users.

INDIANAPOLIS — New court documents from Ohio show the suspect in the disappearance of 17-year-old Hailey Buzbee talked to her for a year before allegedly taking her from her Fishers home. They ...

Have you ever used an application called Chat & Ask AI? If so, there's a good chance your messages were exposed last month. In January, an independent researcher was able to easily access some 300 ...

Spotify is changing how its APIs work in Developer Mode, its layer that lets developers test their third-party applications using the audio platform’s APIs. The changes include a mandatory premium ...

A Chrome extension posing as an AI assistant exposed more than 10,000 users, secretly harvesting OpenAI API keys and sending data to attacker-controlled servers. Researchers say at least 459 API keys ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. If you’ve ever tried to lose weight in America, ...

On Version History: the long reign of AOL Instant Messenger, the messaging app that maybe never should have existed at all. On Version History: the long reign of AOL Instant Messenger, the messaging ...

Python has become one of the most popular programming languages out there, particularly for beginners and those new to the hacker/maker world. Unfortunately, while it’s easy to get something up and ...

A simple, scalable hospital program improved hand hygiene, sped up sepsis treatment, and sharply reduced severe infection outcomes, showing how small, coordinated changes can save mothers’ lives even ...

Finally, a way to prove to all your friends you're right about a topic: Invite them all into a group chat with ChatGPT, then have the AI assert dominance on your behalf. A few days ago, OpenAI started ...

More than 300,000 women are diagnosed with ovarian cancer globally each year. The four-year clinical trial across 15 Australian hospitals – known as SOLACE2 – was co-led by the University of Sydney ...